Hypercalcemia - Market Insight, Epidemiology and Market Forecast - 2030

Hypercalcemia is a condition which leads to a high level of calcium in the blood. Calcium is essential for the normal functioning of the body parts such as organs, cells, muscles, and nerves, however, a too high concentration in the body can cause problems and sometimes can lead to life-threatening conditions also. Some common symptoms for Hypercalcemia include Headaches, Loss of appetite, Depression, Constipation and abdominal (belly) pain, weakness, or muscle pain and many others. Hypercalcemia complications can lead to health complications such as Kidney stones, Kidney failure, osteoporosis, abnormal heart rhythms, bone pain and many other conditions.
Some of the key companies in the Hypercalcemia market include Mylan, Novartis AG, Pfizer, Amgen, AbbVie, Bayer Pharma and many others.
For more details on Hypercalcemia Market, visit:
https://www.delveinsight.com...